Home › Compare › IVBT vs RYLD

IVBT vs RYLD: Dividend Comparison 2026

IVBT yields 1000000.00% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IVBT wins by $4.7683925249533696e+36M in total portfolio value
10 years
IVBT
IVBT
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full IVBT calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — IVBT vs RYLD

📍 IVBT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIVBTRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IVBT + RYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IVBT pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVBT
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, IVBT beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVBT + RYLD for your $10,000?

IVBT: 50%RYLD: 50%
100% RYLD50/50100% IVBT
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVBT buys
0
RYLD buys
0
No recent congressional trades found for IVBT or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIVBTRYLD
Forward yield1000000.00% ✓12.14%
Annual dividend / share$2.00 ✓$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.7683925249533696e+36M$44.5K ✓
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓$2,587.35
Total dividends collected$4.7683311610149396e+36M$18.8K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: IVBT vs RYLD ($10,000, DRIP)

YearIVBT PortfolioIVBT Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$100,010,700$100,000,000.00$11,914$1,213.65+$100.00M → IVBT
2$934,786,450,701$934,679,439,252.34$14,099$1,351.30+$934786.44M → IVBT
3$8,165,787,108,578,292$8,164,786,887,076,042.00$16,580$1,494.55+$8165787108.56M → IVBT
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$19,384$1,642.61+$66665884190957.63M → IVBT
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$22,535$1,794.70+$508662171058048128.00M → IVBT
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$26,063$1,950.00+$3.62723524842849e+21M → IVBT
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$29,995$2,107.69+$2.417368115915061e+25M → IVBT
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$34,361$2,266.99+$1.5056740286145463e+29M → IVBT
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$39,194$2,427.12+$8.764771002818475e+32M → IVBT
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$44,525$2,587.35+$4.7683925249533696e+36M → IVBT

IVBT vs RYLD: Complete Analysis 2026

IVBT — Stock

Innovation1 Biotech Inc., a drug discovery company, focuses on the development of modified schedule 1 molecules of botanical origin in the United States. Its portfolio includes five proprietary fully synthetic preclinical prodrugs addressing independent clinical indications comprising a mushroom-derived psychedelic molecule for treatment of post-traumatic stress disorder and depression; a novel cannabinoid and tree bark derived psychedelic for treatment of addiction; and three additional cannabinoid prodrugs addressing clinical indications of refractory pediatric epilepsy, hypertrophic scarring, and ocular inflammation. The company was formerly known as Gridiron BioNutrients, Inc. and changed its name to Innovation1 Biotech Inc. in March 2022. Innovation1 Biotech Inc. was founded in 2014 and is headquartered in New York, New York.

Full IVBT Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this IVBT vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVBT vs SCHDIVBT vs JEPIIVBT vs OIVBT vs KOIVBT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.